Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-124955
Filing Date
2016-06-02
Accepted
2016-06-01 21:47:17
Documents
96
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11661_110q.htm 10-Q 1395005
2 EX-31.1 a16-11661_1ex31d1.htm EX-31.1 9054
3 EX-31.2 a16-11661_1ex31d2.htm EX-31.2 8991
4 EX-32.1 a16-11661_1ex32d1.htm EX-32.1 4471
5 EX-32.2 a16-11661_1ex32d2.htm EX-32.2 4487
  Complete submission text file 0001104659-16-124955.txt   10119921

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20150630.xml EX-101.INS 2575734
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20150630.xsd EX-101.SCH 92126
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20150630_cal.xml EX-101.CAL 79399
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20150630_def.xml EX-101.DEF 334132
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT akrx-20150630_lab.xml EX-101.LAB 582513
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20150630_pre.xml EX-101.PRE 574615
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 161690824
SIC: 2834 Pharmaceutical Preparations